Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) drugs. Its structure supports the design of compounds with improved metabolic stability and blood-brain barrier penetration. Commonly utilized in the preparation of investigational drugs targeting neurological disorders such as depression, schizophrenia, and cognitive impairments. The fluorinated piperidine core enhances binding affinity to specific neuronal receptors, making it valuable in medicinal chemistry for optimizing drug candidates. Also employed in structure-activity relationship (SAR) studies to refine potency and selectivity of new therapeutic molecules.